IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $195,002 | -65.1% | 107,144 | -2.7% | 0.01% | -71.4% |
| Q4 2022 | $558,197 | -42.4% | 110,098 | -43.6% | 0.02% | -34.4% |
| Q3 2022 | $969,000 | +20.5% | 195,127 | -9.7% | 0.03% | +33.3% |
| Q2 2022 | $804,000 | -28.9% | 215,973 | +7.1% | 0.02% | -17.2% |
| Q1 2022 | $1,131,000 | +10.4% | 201,588 | +19.7% | 0.03% | +7.4% |
| Q4 2021 | $1,024,000 | +7.6% | 168,476 | +72.3% | 0.03% | -6.9% |
| Q3 2021 | $952,000 | -36.4% | 97,754 | -6.7% | 0.03% | -35.6% |
| Q2 2021 | $1,496,000 | – | 104,736 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |